…
Can daily aspirin help to stop oesophageal cancer from coming back?
'The NCRI Upper Gastrointestinal Group has published the following article outlining the Add-Asprin trial. We all know aspirin as a…
NCRI Group members challenging the status quo in brain tumour research
'Members of the NCRI Brain Group have published a position statement arguing that there is not enough evidence to support…
Using online symptom reporting to manage cancer symptoms
'A trial has found that cancer patients can benefit from regular online symptom reporting combined with a computer algorithm to…
Study identifies challenges in involving young people in research
'Evaluating specialist care for young people with cancer was identified as a research priority by the NCRI Teenage and Young…
Strengthening the research workforce through NCRI Group membership
'Dr Simon Mitchell is a member of the Science Subgroup of the NCRI Lymphoma Group and has recently been awarded…
NCRI Lymphoma Group member receives UKRI fellowship
'Congratulations to Dr Simon Mitchell, who is a member of the Science Subgroup of the NCRI Lymphoma Group, on being…
Artificial intelligence can help to improve prognosis and treatment for glioblastoma
'In the first study of its kind in cancer, researchers have applied artificial intelligence to measure the amount of muscle…
What should we call patient representatives and advocates?
'The National Cancer Research Institute (NCRI) has led the way in involving patients, carers and other people with experience of…
UK cancer research could see £167m drop in funding as a result of charity income loss
'Due to the impact of the Covid-19 pandemic, cancer research charities are predicting their spending on research could drop by…
Accurate detection of prostate cancer and the crucial role of patient involvement
'The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…
The language of cancer and COVID-19 – helpful or harmful?
'Janette Rawlinson is a consumer member of NCRI’s lung cancer advanced disease sub-group and Consumer Forum, steering committee member of…